| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.085 | 0.2 |